How Biogen’s Aduhelm Bet Became A Commercial Bust

 
• By Mandy Jackson and Mary Jo Laffler
  
Aduhelm: One Year Later
Biogen's big Aduhelm bet has resulted in big financial and personnel losses • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip